Pharmabiz

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Pharmabiz

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...
Pharmabiz

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery: King of Prussia, Pennsylvania Saturday, February 28, 2026, 17:00 Hrs [IST] Core Solutions (Core ...
Pharmabiz

Eli Lilly's oral GLP-1, orforglipron outperforms blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial

Eli Lilly's oral GLP-1, orforglipron outperforms blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial: Our Bureau, Mumbai Saturda ...
Pharmabiz

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...
Pharmabiz

CDSCO introduces SHRESTH index to improve performance of state drug regulatory authorities

CDSCO introduces SHRESTH index to improve performance of state drug regulatory authorities: Shardul Nautiyal, Mumbai Saturday ...
Pharmabiz

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
Pharmabiz

START appoints Dr Frank Smith as president of its XenoSTART preclinical research business unit

START appoints Dr Frank Smith as president of its XenoSTART preclinical research business unit: San Antonio, Texas Friday, ...
Pharmabiz

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...
Pharmabiz

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing: London Saturday, February 28, 2026, 13:00 Hrs [IST] ViiV Heal ...
Pharmabiz

IDEAYA Biosciences begins patient enrolment in phase 1 trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC

IDEAYA Biosciences begins patient enrolment in phase 1 trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC: South San Francisco, California Friday, February 27, 2026 ...
Pharmabiz

TN, Karnataka, Rajasthan declare highest number of NSQs in January

TN, Karnataka, Rajasthan declare highest number of NSQs in January: Gireesh Babu, New Delhi Saturday, February 28, 2026, 08:00 Hrs [IST] Around 29% of the total Not of Standard Qu ...